NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,359,463 | +9.9% | 247,106 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $10,338,143 | +123.8% | 245,154 | +38.4% | 0.00% | +100.0% |
| Q1 2023 | $4,620,330 | -13.0% | 177,092 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $5,309,595 | +95.4% | 178,294 | +27.6% | 0.00% | 0.0% |
| Q3 2022 | $2,717,000 | +57.1% | 139,778 | +9.6% | 0.00% | – |
| Q2 2022 | $1,730,000 | -10.8% | 127,586 | -8.6% | 0.00% | – |
| Q1 2022 | $1,939,000 | +3.4% | 139,571 | +41.7% | 0.00% | – |
| Q4 2021 | $1,875,000 | -11.3% | 98,497 | +5.0% | 0.00% | – |
| Q3 2021 | $2,115,000 | – | 93,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
| Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
| VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
| Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
| BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
| Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
| Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
| Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |